M. Haagenson

发表

High HLA-DP Expression and Graft-versus-Host Disease.

Effie W Petersdorf, Mari Malkki, Mary Carrington, 2015, The New England journal of medicine.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

L. Weiner, Jeffrey S. Miller, J. Ross, 2014, Blood.

MYELOID NEOPLASIA CD 16 xCD 33 bispeci fi c killer cell engager ( BiKE ) activates NK cells against primary MDS and MDSC CD 33 1 targets

L. Weiner, Jeffrey S. Miller, J. Ross, 2014 .

Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

P. Parham, Jeffrey S. Miller, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR Donor Selection: Feasibility in Identifying better Donors.

P. Parham, S. Marsh, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

J. Chewning, K. Hsu, B. Dupont, 2012, The New England journal of medicine.

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

J. Dipersio, D. Porter, S. Farag, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.

J. Klein, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.

J. Klein, Jeffrey S. Miller, S. Spellman, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

J. Klein, P. Parham, M. Horowitz, 2007, Blood.

Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths.

Lara E Sucheston-Campbell, Abbas A. Rizvi, C. Haiman, 2019, Blood advances.

Patient HLA Germline Variation and Transplant Survivorship.

R. Strong, M. Horowitz, M. Malkki, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2017, The New England journal of medicine.

Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

S. Savage, H. Katki, K. Jones, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

D. Porter, M. Horowitz, K. Hsu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1

D. Miklos, Stephanie J. Lee, M. Heemskerk, 2014, Bone Marrow Transplantation.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

S. Spellman, M. Fernandez-Vina, C. Hurley, 2013 .

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

J. Klein, M. Horowitz, Stephanie J. Lee, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

E. Warren, S. Spellman, Tao Wang, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

M. Horowitz, M. Maiers, S. Marsh, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes

L. Tian, J. Ritz, D. Miklos, 2016, Haematologica.

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

J. Klein, S. Spellman, C. Anasetti, 2007, Blood.

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

S. Savage, H. Katki, Stephanie J. Lee, 2018, Blood.

Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.

R. Scheuermann, A. Telenti, M. Heuer, 2018, Blood advances.

The influence of interleukin‐7 receptor α‐chain haplotypes on outcome after allogeneic hematopoietic cell transplantation

S. Spellman, N. Hellings, P. Stinissen, 2014, International journal of immunogenetics.

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

J. Klein, M. Horowitz, P. Cano, 2013, Blood.

Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Stephanie J. Lee, S. Spellman, Tao Wang, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, J. Klein, M. Horowitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.

J. Klein, M. Horowitz, B. Logan, 2009, Blood.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

E. Reed, J. Boudreau, K. Hsu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2013, Blood.

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

J. Klein, Stephanie J. Lee, S. Spellman, 2012, Haematologica.

Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.

S. Savage, K. Jones, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

S. Savage, Stephanie J. Lee, I. De Vivo, 2015, JAMA.

No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

S. Savage, K. Hsu, Stephanie J. Lee, 2017, Bone Marrow Transplantation.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

S. Tarima, O. Ringdén, P. McCarthy, 2011, Bone Marrow Transplantation.

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

K. Hsu, Jeffrey S. Miller, J. Fischer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymorphism in the Interleukin‐7 Receptor‐alpha and Outcome after Allogeneic Hematopoietic Cell Transplantation with Matched Unrelated Donor

S. Spellman, L. Ryder, M. Haagenson, 2013, Scandinavian journal of immunology.

HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Tao Wang, Machteld Oudshoorn, M. Horowitz, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnosis of suspected hypovitaminosis A using magnetic resonance imaging in African lions (Panthera leo).

M. Haagenson, R. Kirberger, L. Sweers, 2005, Journal of the South African Veterinary Association.

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.

J. Klein, S. Takemoto, S. Spellman, 2007, Blood.

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

P. Parham, Jeffrey S. Miller, S. Marsh, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A CIBMTR Study

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019 .

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.

M. Horowitz, M. Malkki, S. Spellman, 2013, Blood.

TRANSPLANTATION Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

M. Malkki, S. Spellman, Tao Wang, 2013 .

MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation

M. Horowitz, M. Malkki, S. Spellman, 2012, Science Translational Medicine.

Petersdorf Hematopoietic Cell Transplantation MHC-Resident Variation Affects Risks After Unrelated Donor

M. Horowitz, M. Malkki, S. Spellman, 2012 .

Mapping MHC-resident transplantation determinants.

F. Christiansen, M. Horowitz, M. Malkki, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

M. Carrington, C. Witt, R. Apps, 2014, Blood.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Harriet Noreen, Marcelo Fernandez-Vina, John Klein, 2007, Blood.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR

A. Nagler, M. Mohty, K. Hsu, 2018, Bone Marrow Transplantation.

Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

A. Ganser, D. Miklos, M. Aljurf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

J. Klein, P. Parham, Jeffrey S. Miller, 2014, The Journal of Immunology.

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

John P. Klein, Martin Maiers, T. Andrew Binkowski, 2011, Bone Marrow Transplantation.

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

A. Gratwohl, J. Szer, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel HLA-DP region susceptibility loci associated with severe acute GvHD

R. Ferrell, S. Spellman, M. Trucco, 2017, Bone Marrow Transplantation.

J. Wingard, M. Bishop, G. Switzer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

M. Aljurf, Stephanie J. Lee, S. Marsh, 2014, Blood.

Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.

S. Chanock, M. Yeager, S. Savage, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Tao Wang, John Horan, Machteld Oudshoorn, 2012, Blood.

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.

J. Wagner, M. Horowitz, J. Wingard, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Bone Marrow Transplantation.

Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.

J. Cerhan, M. Carrington, N. Rothman, 2020, American journal of human genetics.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

J. Klein, Stephanie J. Lee, O. Ringdén, 2008 .

P. Bierman, E. Montserrat, K. Ballen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Limited HLA sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor‐recipient pairs

S. Spellman, C. Vierra-Green, C. Brady, 2017, HLA.

Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.

J. Klein, R. Blasczyk, Jun He, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis

P. Parham, Stephanie J. Lee, S. Spellman, 2019 .

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

K. Hsu, Stephanie J. Lee, O. Ringdén, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelogenous Leukemia Unrelated Transplantation for Acute Mismatch Enhance the Clinical Benefit of Haplotypes, Recipient HLA-C1, and HLA-C Donor Killer Cell Ig-like Receptor B

Martha, Jeffrey, J. Klein, 2014 .

MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Mar

K. Hsu, Stephanie J. Lee, A. Madbouly, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.

N. Davidson, Stephanie J. Lee, Ellen Li, 2010, Blood.

Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.

V. Paunic, K. Hsu, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101.

C K Hurley, S Dakshanamurthy, S. Dakshanamurthy, 2009, Tissue antigens.

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

J. Klein, P. Parham, M. Horowitz, 2006 .

Program cells: results of a prospective trial from the National Marrow Donor Adverse events among 2408 unrelated donors of peripheral blood stem

B. Logan, S. Leitman, A. Pulsipher, 2012 .

Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

P. Kraft, R. Abdi, P. Jindra, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task

T. A. Binkowski, T. Karrison, M. Maiers, 2016, Bone Marrow Transplantation.

Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation.

Jeffrey S. Miller, S. Spellman, Tao Wang, 2009, Blood.

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2016 .

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

J. Klein, M. Horowitz, Stephanie J. Lee, 2006 .

Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation.

Stephanie J. Lee, S. Spellman, Tao Wang, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, M. Horowitz, S. Spellman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

C. Le, P. Parham, Jeffrey S. Miller, 2010, Blood.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

R. Apps, A. Velardi, K. Hsu, 2014, Blood.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Stephanie J. Lee, S. Spellman, Tao Wang, 2012, Blood.

TRANSPLANTATION Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

J. Pidala, S. Santarone, M. Maiers, 2013 .

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

M. Carrington, E. Tholouli, C. Crawley, 2019, The Lancet. Haematology.

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

M. Horowitz, R. Gale, Stephanie J. Lee, 2010 .

Hla-c Expression Levels Define Permissible Mismatches in Hematopoietic Cell Transplantation Key Points

M. Horowitz, E. Petersdorf, T. Gooley, 2022 .

Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation.

W. Guan, K. Hsu, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

L. Weiner, Jeffrey S. Miller, J. Ross, 2014, Blood.

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

E. Reed, K. Hsu, M. Malkki, 2012 .